90 related articles for article (PubMed ID: 18780650)
21. [The effect of glycine with timoptol on the rabbit IOP physiological values].
Veselovský J; Oláh Z; Veselá A; Gressnerová S
Cesk Slov Oftalmol; 2006 Jul; 62(4):247-54. PubMed ID: 16895057
[TBL] [Abstract][Full Text] [Related]
22. γ-Cyclodextrin nanoparticle eye drops with dorzolamide: effect on intraocular pressure in man.
Gudmundsdottir BS; Petursdottir D; Asgrimsdottir GM; Gottfredsdottir MS; Hardarson SH; Jóhannesson G; Kurkov SV; Jansook P; Loftsson T; Stefánsson E
J Ocul Pharmacol Ther; 2014 Feb; 30(1):35-41. PubMed ID: 24205991
[TBL] [Abstract][Full Text] [Related]
23. [The ocular hypotensive effect of the combination of latanoprost with dorzolamide].
Chiselita D; Apatachioae I; Poiata I
Oftalmologia; 1999; 46(1):39-45. PubMed ID: 10641085
[TBL] [Abstract][Full Text] [Related]
24. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
[TBL] [Abstract][Full Text] [Related]
25. Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits.
Loma P; Guzman-Aranguez A; de Lara MJP; Pintor J
J Optom; 2018; 11(2):69-74. PubMed ID: 29132913
[TBL] [Abstract][Full Text] [Related]
26. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
Lupinacci AP; Netland PA; Fung KH; Evans D; Zhao Y
Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
[TBL] [Abstract][Full Text] [Related]
27. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
28. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
Egorov AE
Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485
[TBL] [Abstract][Full Text] [Related]
29. Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study.
Francis BA; Du LT; Berke S; Ehrenhaus M; Minckler DS;
J Clin Pharm Ther; 2004 Aug; 29(4):375-80. PubMed ID: 15271105
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of dorzolamide–timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: the COSOPT first-line study.
Crichton AC; Harasymowycz P; Hutnik CM; Behki R; Boucher S; Ibrahim F; Rifkind AW; Solomon L; Liao C; Bastien NR; Sampalis JS
J Ocul Pharmacol Ther; 2010 Oct; 26(5):503-11. PubMed ID: 20874498
[TBL] [Abstract][Full Text] [Related]
31. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans.
Ishii K; Tomidokoro A; Nagahara M; Tamaki Y; Kanno M; Fukaya Y; Araie M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2957-63. PubMed ID: 11687542
[TBL] [Abstract][Full Text] [Related]
32. Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles.
Park CG; Kim YK; Kim SN; Lee SH; Huh BK; Park MA; Won H; Park KH; Choy YB
Int J Pharm; 2017 Apr; 522(1-2):66-73. PubMed ID: 28216468
[TBL] [Abstract][Full Text] [Related]
33. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
Shin DH; Feldman RM; Sheu WP;
Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
[TBL] [Abstract][Full Text] [Related]
35. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
Konstas AG; Mikropoulos D; Dimopoulos AT; Moumtzis G; Nelson LA; Stewart WC
Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment.
Natu MV; Gaspar MN; Fontes Ribeiro CA; Cabrita AM; de Sousa HC; Gil MH
Int J Pharm; 2011 Aug; 415(1-2):73-82. PubMed ID: 21641984
[TBL] [Abstract][Full Text] [Related]
37. Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes.
Dietrich UM; Chandler MJ; Cooper T; Vidyashankar A; Chen G
Vet Ophthalmol; 2007; 10 Suppl 1():95-100. PubMed ID: 17973840
[TBL] [Abstract][Full Text] [Related]
38. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA
Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516
[TBL] [Abstract][Full Text] [Related]
39. [Effect of Trusopt on normal intraocular pressure values in children].
Rehůrek J; Spicarová R; Vancurová J
Cesk Slov Oftalmol; 2000 Oct; 56(6):366-9. PubMed ID: 11225268
[TBL] [Abstract][Full Text] [Related]
40. Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.
Fuwa M; Ueda K; Akaishi T; Yamashita N; Kirihara T; Shimazaki A; Mano H; Kawazu K
PLoS One; 2016; 11(7):e0158797. PubMed ID: 27383260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
